As of 2025-07-19, the Relative Valuation of 9 Meters Biopharma Inc (NMTR) is (35.78) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.07 USD, the upside of 9 Meters Biopharma Inc based on Relative Valuation is -49651.1%.
The range of the Relative Valuation is (36.25) - (34.83) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.0x - 18.6x | 18.2x |
| Forward P/E multiples | 19.4x - 21.5x | 20.1x |
| Fair Price | (36.25) - (34.83) | (35.78) |
| Upside | -50311.7% - -48342.7% | -49651.1% |
| Date | P/E |